Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Regulatory News (INS)

  • There is currently no data for INS

Board Changes and Delisting

8 Jul 2005 16:36

Eagerport Limited08 July 2005 Immediate Release 8 July 2005 This announcement is not for release, publication or distribution in or intoCanada, Australia or Japan. ANIXTER INTERNATIONAL INC and INFAST GROUP PLC INFAST BOARD CHANGES AND DELISTING Earlier today Eagerport Limited (a wholly-owned indirect subsidiary of AnixterInternational Inc.) announced that the Offer for the entire issued share capitalof Infast Group plc had been declared unconditional in all respects. Infast Board Changes Infast announces that, this afternoon, Dennis Letham, John Dul, Philippe Walpot,William Banks and Alexandra Holland joined the board of Infast. Dennis Lethamhas been appointed CEO of the Company, William Banks has been appointed asFinance Director, John Dul, Philippe Walpot and Alexandra Holland have beenappointed Executive Directors. Richard Seguin, Anthony Bruce, Graham Titcombe,Michael Parker, Robert Sternick, and John Kimber have resigned from the board. In connection with the appointments, there are no details that are required tobe disclosed by paragraph 9.6.13 of the Listing Rules of the UK ListingAuthority ("UKLA"). Delisting Application has been made by Infast to the UKLA for the cancellation of listingof Infast Shares on the Official List of the UKLA and to the London StockExchange for the cancellation of the admission to trading of Infast Shares onthe London Stock Exchange's market for listed securities. It is anticipatedthat cancellation of listing and admission to trading will take effect from 8August 2005, being 20 Business Days following the date of this announcement. Terms defined in the Offer Document have the same meanings in this announcement. Enquiries: Anixter Dennis Letham Tel: +1 224 521 8601KPMG Corporate Finance Charles E Cattaneo Tel: +44 (0) 121 232 3356Buchanan Communications Charles Ryland Tel: +44 (0) 20 7466 5000 James Strong Tel: +44 (0) 20 7466 5000 KPMG Corporate Finance, a division of KPMG LLP which is authorised and regulatedby the Financial Services Authority for investment business activities, isacting for Anixter and the Offeror as financial adviser in relation to the Offerand is not acting for any other person in relation to the Offer. KPMG CorporateFinance will not be responsible to anyone other than Anixter and the Offeror forproviding the protections afforded to its clients or for providing advice inrelation to the contents of this announcement or any transaction or arrangementreferred to herein. This announcement does not constitute an offer or invitation to purchase anysecurities or the solicitation of an offer to buy any securities, pursuant tothe Offer or otherwise. The Offer is being made solely pursuant to the OfferDocument and the Form of Acceptance accompanying the Offer Document, whichcontain the full terms and conditions of the Offer, including details of how theOffer may be accepted. The Offer is not being made, directly or indirectly, in or into, or by use ofthe mails of, or by any means or instrumentality (including, without limitation,facsimile transmission, electronic mail, telex or telephone) of interstate orforeign commerce of, or any facilities of a national securities exchange ofCanada, Australia, Japan or any jurisdiction where to do so would violate thelaws in that jurisdiction and the Offer will not be capable of acceptance by anysuch use, means, instrumentality or facility, directly or indirectly from orwithin Canada, Australia, Japan or any such jurisdiction. The Offer in the United States is being made solely by the Offeror, and neitherKPMG LLP, KPMG Corporate Finance, nor any of its respective affiliates, ismaking the Offer in the United States. The members of the Anixter Offer Committee accept responsibility for theinformation contained in this announcement relating to Anixter and the Offeror.To the best of the knowledge and belief of the members of the Anixter OfferCommittee (who have taken all reasonable care to ensure that such is the case),the information contained in this announcement for which they acceptresponsibility is in accordance with the facts and does not omit anything likelyto affect the import of such information. The Offeror Directors accept responsibility for the information contained inthis announcement relating to the Offeror. To the best of the knowledge andbelief of the Offeror Directors (who have taken all reasonable care to ensurethat such is the case), the information contained in this announcement for whichthey accept responsibility is in accordance with the facts and does not omitanything likely to affect the import of such information. END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Feb 201610:17 amRNSHolding(s) in Company
23rd Feb 20161:32 pmRNSResult of General Meeting and Director Dealings
12th Feb 20167:00 amRNSInvestor Presentation
5th Feb 20164:47 pmRNSIssue of Equity and Total Voting Rights
4th Feb 20167:00 amRNSDirector/PDMR Shareholding
3rd Feb 20167:00 amRNSPlacing, Posting of Circular and Notice of GM
25th Jan 20167:00 amRNSInnovators & Investors Forum
13th Jan 20167:00 amRNSTrading Update
23rd Dec 20151:15 pmRNSDirector Shareholding and Other Holdings
8th Dec 20153:53 pmRNSIssue of Equity and Total Voting Rights
1st Dec 20157:00 amRNSLogos Earn Out, Issue of Equity and TVR
30th Nov 20155:59 pmRNSHolding(s) in Company
29th Sep 20157:00 amRNSHalf Yearly Report
6th Aug 201511:55 amRNSAdmission of Ordinary Shares
3rd Aug 20157:00 amRNSLogos Third Earn Out Payment & Total Voting Rights
30th Jul 20157:00 amRNSTrading Update and Notice of Interim Results
29th Jul 20157:01 amRNSGrants Under the Long Term Incentive Plan
23rd Jun 20157:00 amRNSInvestor Teach-in
21st May 20154:39 pmRNSHolding(s) in Company
19th May 20151:16 pmRNSResult of AGM
14th May 20157:00 amRNSInstem ALPHADAS Contract Wins
27th Apr 20159:16 amRNSPosting of Annual Report and Notice of AGM
30th Mar 20157:00 amRNSFinal Results
16th Mar 20157:00 amRNSNotice of Results
13th Feb 20157:00 amRNSPerceptive Instruments Earn Out Payment
27th Jan 20157:01 amRNSInnovators & Investors Forum (London)
12th Jan 20157:00 amRNSTrading Update and Notice of Results
23rd Dec 201411:52 amRNSHolding(s) in Company
18th Dec 20147:00 amRNSWIL Research Contract Extension
10th Nov 20147:00 amRNSCentrus-submit Contract Wins
24th Sep 20147:00 amRNSUnaudited Interim Results
5th Sep 20147:00 amRNSNotice of Results
13th Aug 201410:27 amRNSHolding(s) in Company
1st Aug 20147:00 amRNSLogos Second Earn Out Payment
16th Jul 20147:00 amRNSTwo contract wins in Asia-Pacific
21st May 201411:45 amRNSResult of AGM
1st May 20147:00 amRNSContract win
25th Apr 20147:00 amRNSPosting of Annual Report and Notice of AGM
26th Mar 20147:01 amRNSUS Government Contract Extension
26th Mar 20147:00 amRNSFinal Results
6th Mar 20147:00 amRNSNotice of Results
20th Feb 20147:00 amRNSThree-Year SaaS Contract with Leading Pharma
7th Feb 20141:05 pmRNSHolding(s) in Company
3rd Feb 20147:00 amRNSLogos Initial Earn Out Payment
8th Jan 20147:00 amRNSTrading Update and Notice of Results
22nd Nov 20137:00 amRNSAcquisition and Trading Update
9th Oct 20137:00 amRNSAppointment of VP Global Sales
25th Sep 20137:00 amRNSHalf Yearly Report
15th Aug 20137:00 amRNSNotice of Results
2nd Jul 20137:00 amRNSFirst Contract Win for Instem Clinical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.